Similarly, the miR-21 inhibitor diminished the expression of α-SMA and Col1A1 in activated HSCs, by a mechanism with demonstrated therapeutic potential in liver fibrosis (Fu et al., 2017). Here, ACTA1 is linked to Hepatic fibrosis.